UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain

Gene therapy, 2013-12, Vol.20 (12), p.1178-1183

2013

Volltextzugriff (PDF)

MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain

Gene therapy, 2017-04, Vol.24 (4), p.253-261

2017

Volltextzugriff (PDF)

Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response

Gene therapy, 2016-04, Vol.23 (4), p.393-398

2016

Volltextzugriff (PDF)

Clozapine Preferentially Increases Dopamine Release in the Rhesus Monkey Prefrontal Cortex Compared with the Caudate Nucleus

Neuropsychopharmacology (New York, N.Y.), 1999-05, Vol.20 (5), p.403-412

1999

Volltextzugriff (PDF)

Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF

The Journal of neuroscience, 2010-07, Vol.30 (28), p.9567-9577

2010

Volltextzugriff (PDF)

Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys

Human gene therapy, 2009-12, Vol.20 (12), p.1627

2009

Volltextzugriff (PDF)

Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response

Human gene therapy, 2009-03, Vol.20 (3), p.225

2009

Volltextzugriff (PDF)

Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain

Human gene therapy, 2006-03, Vol.17 (3), p.291

2006

Volltextzugriff (PDF)

Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum

Human gene therapy, 2012-02, Vol.23 (2), p.210

2012

Volltextzugriff (PDF)

Convection-Enhanced Delivery of AAV Vector in Parkinsonian Monkeys; In Vivo Detection of Gene Expression and Restoration of Dopaminergic Function Using Pro-drug Approach

Experimental neurology, 2000-07, Vol.164 (1), p.2-14

2000

Volltextzugriff (PDF)

In vivo PET imaging of gene expression in parkinsonian monkeys

Molecular therapy, 2003-12, Vol.8 (6), p.873-875

2003

Volltextzugriff (PDF)

Tremor Is Associated with PET Measures of Nigrostriatal Dopamine Function in MPTP-Lesioned Monkeys

Experimental neurology, 2000-10, Vol.165 (2), p.342-346

2000

Volltextzugriff (PDF)

Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys

Experimental neurology, 2006-02, Vol.197 (2), p.363-372

2006

Volltextzugriff (PDF)

Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys

Neuroreport, 2006-02, Vol.17 (2), p.201-204

2006

Volltextzugriff (PDF)

Comparison of two methods for the analysis of [ 18F]6-fluoro- l- m-tyrosine PET data

NeuroImage (Orlando, Fla.), 2004-09, Vol.23 (1), p.358-363

2004

Volltextzugriff (PDF)

Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats

Psychopharmacologia, 1991-03, Vol.103 (3), p.407-414

1991

Volltextzugriff (PDF)

The Immunophilin Ligand GPI-1046 Does Not Have Neuroregenerative Effects in MPTP-Treated Monkeys

Experimental neurology, 2002-12, Vol.178 (2), p.236-242

2002

Volltextzugriff (PDF)

A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes

Brain research, 1998-09, Vol.805 (1), p.259-262

1998

Volltextzugriff (PDF)

Technique for Bilateral Intracranial Implantation of Cells in Monkeys Using an Automated Delivery System

Cell transplantation, 2000-09, Vol.9 (5), p.595-607

2000

Volltextzugriff (PDF)

Dopamine transporter loss and clinical changes in MPTP-lesioned primates

Brain research, 1999-06, Vol.832 (1-2), p.184-187

1999

Volltextzugriff (PDF)

Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes

Frontiers in bioscience, 2003-09, Vol.8, p.a155

2003

Volltextzugriff (PDF)

Application of gene therapy for Parkinson's disease: nonhuman primate experience

Advances in pharmacology (1990), 1998, Vol.42, p.801

1998

Volltextzugriff (PDF)

Thermoregulatory consequences of long-term microwave exposure at controlled ambient temperatures

Bioelectromagnetics, 1985, Vol.6 (4), p.339-363

1985

Volltextzugriff (PDF)

Application of Gene Therapy for Parkinson's Disease: Nonhuman Primate Experience

Advances in Pharmacology, 1997, Vol.42, p.801-806

1997

Volltextzugriff (PDF)

AAV9-mediated Expression of a Non-self Protein in Nonhuman Primate Central Nervous System Triggers Widespread Neuroinflammation Driven by Antigen-presenting Cell Transduction

Molecular therapy, 2014-02, Vol.22 (2), p.329-337

2014

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(46)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(38)
Animals
(26)
Humans
(24)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Male
(20)
Macaca Mulatta
(19)
Female
(15)
Medicine, Research & Experimental
(14)
Research & Experimental Medicine
(14)
Biotechnology & Applied Microbiology
(11)
Gene Therapy
(11)
Genetics & Heredity
(11)
Neurosciences
(11)
Neurosciences & Neurology
(11)
Neurology
(10)
Parkinson's Disease
(10)
Asthma - Chemically Induced
(9)
Toluene 2,4-Diisocyanate - Adverse Effects
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain

MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain

Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response

Clozapine Preferentially Increases Dopamine Release in the Rhesus Monkey Prefrontal Cortex Compared with the Caudate Nucleus

Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF

Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys

Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response

Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain

Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum

Convection-Enhanced Delivery of AAV Vector in Parkinsonian Monkeys; In Vivo Detection of Gene Expression and Restoration of Dopaminergic Function Using Pro-drug Approach

In vivo PET imaging of gene expression in parkinsonian monkeys

Tremor Is Associated with PET Measures of Nigrostriatal Dopamine Function in MPTP-Lesioned Monkeys

Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys

Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys

Comparison of two methods for the analysis of [ 18F]6-fluoro- l- m-tyrosine PET data

Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats

The Immunophilin Ligand GPI-1046 Does Not Have Neuroregenerative Effects in MPTP-Treated Monkeys

A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes

Technique for Bilateral Intracranial Implantation of Cells in Monkeys Using an Automated Delivery System

Dopamine transporter loss and clinical changes in MPTP-lesioned primates

Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes

Application of gene therapy for Parkinson's disease: nonhuman primate experience

Thermoregulatory consequences of long-term microwave exposure at controlled ambient temperatures

Application of Gene Therapy for Parkinson's Disease: Nonhuman Primate Experience

AAV9-mediated Expression of a Non-self Protein in Nonhuman Primate Central Nervous System Triggers Widespread Neuroinflammation Driven by Antigen-presenting Cell Transduction

Suchergebnisse filtern